Pharma IQ Members

Endpoint

An Endpoint is defined as the point at which an experimental animal's pain and/or distress is terminated, minimized or reduced by taking actions such as humanely killing the animal, terminating a painful procedure, or giving treatment to relieve pain and/or distress.

Surya Chitra, PhD, MBA, Biostatistics and Pharmacology, and Gary Fishbein, MD, MPH,

Surya Chitra, PhD, MBA, Biostatistics and Pharmacology, and Gary Fishbein, MD, MPH, Senior Medical Director, PharmaNet Development Group, Inc, join Pharma IQ to discuss adaptive trial design.Pharma IQ: Could you just outline your current roles?S...

Contributor: Surya Chitra, PhD, MBA, Biostatistics and Pharmacology, and Gary Fishbein, MD, MPH,
07/27/2011 08:00:00 PM EDT
Pharma IQ News

Gary Acton, CMO from Antisoma will explore the challenges the contemporary controversy around clinical trials approval faces at Optimising Clinical Development in Oncology, 15th-16th March 2011 in London. Gary Acton will take the example of the...

Contributor: Pharma IQ News
01/04/2011 07:00:00 PM EST
Pharma IQ

Clinical trials may be one of the most fundamental parts of drug development work carried out in the pharmaceutical industry, but they still remain a complicated area for pharma companies to address. The design of trials plays an important role...

Contributor: Pharma IQ
09/28/2010 08:00:00 PM EDT